licoric
dri
root
glycyrrhiza
glabra
glycyrrhiza
inflata
glycyrrhiza
uralensi
member
legum
endogen
asia
southern
europ
wide
use
flavor
sweeten
agent
also
propos
variou
clinic
applic
pharmacolog
effect
licoric
includ
inhibit
gastric
acid
secret
antiinflammatori
antivir
antiatherogen
well
verifi
anticarcinogen
effect
licoric
also
recent
demonstr
biolog
effect
attribut
myriad
biolog
activ
constitu
terpenoid
alkaloid
polysaccharid
polyamin
saponin
flavonoid
import
constitu
licoric
glycyrrhizin
g
acid
present
quantiti
dri
root
g
consist
disaccharid
two
glucuron
acid
molecul
bound
pentacycl
triterpen
glycyrrhetin
acid
ga
exist
two
isom
epim
tran
ga
ci
form
ga
fig
g
exhibit
potent
hydrocortisonelik
antiinflammatori
antiulc
antivir
antihepatotox
activ
wherea
ga
potent
antibiot
ulcer
caus
helicobact
pylori
amount
licoric
root
report
rang
wherea
amount
usual
lower
qualit
differ
pharmacolog
effect
isom
observ
instanc
antihepatotox
activ
higher
antiinflammatori
activ
consider
lower
regard
qualiti
control
qc
analysi
licoric
root
glycyrrhizin
g
often
consid
frequent
monitor
metabolit
via
hplc
nevertheless
hplc
rather
difficult
resolv
stereoisom
satisfactorili
due
similar
properti
epim
paper
report
procedur
distinguish
use
chiral
separ
hptlc
gel
electrophoresi
requir
elabor
chromatographi
separ
isom
interest
g
biolog
activ
improv
qc
analysi
licoric
sampl
drive
develop
faster
stabl
accur
method
reliabl
g
isom
assign
licoric
extract
nmr
present
power
technolog
isol
structur
elucid
includ
conform
nmr
experi
base
either
nuclear
overhaus
enhanc
spectroscopi
noesi
rotat
frame
overhaus
effect
spectroscopi
roesi
provid
inform
coupl
space
consequ
allow
configur
sometim
even
conform
assign
isom
increas
interest
util
nmr
metabol
fingerprint
phytomedicin
qc
analysi
possibl
record
nmr
spectra
crude
plant
extract
provid
valuabl
metabolit
signatur
complex
plant
extract
unlik
msbase
analys
nuclear
magnet
reson
nmr
spectroscopi
provid
larg
amount
inform
regard
molecular
structur
novel
softwar
innov
facilit
unequivoc
identif
compound
within
composit
sampl
howev
nmr
lower
sensit
compar
ms
addit
introduc
anoth
set
chemic
shift
proton
dimens
roesi
spectra
would
also
complic
spectral
process
use
multivari
data
analysi
studi
present
effect
nmr
method
g
isom
assign
licoric
extract
requir
preliminari
chromatographi
purif
step
total
extract
repres
three
differ
glycyrrhiza
speci
g
glabra
g
uralensi
g
inflata
differ
local
analyz
total
wellcharacter
glycyrrhiza
sampl
repres
broad
geograph
genet
sampl
speci
across
world
analyz
inform
collect
sampl
origin
record
tabl
purchas
deutero
gmbh
kastellaun
germani
standard
acid
acid
obtain
sigma
aldrich
st
loui
mo
usa
dri
deep
frozen
glycyrrhiza
root
powder
mg
homogen
ml
meoh
use
turrax
mixer
rpm
five
period
extract
vortex
vigor
centrifug
min
remov
plant
debri
root
specimen
three
biolog
replic
provid
extract
parallel
ident
condit
total
sampl
roesi
analysi
ml
aliquot
solvent
evapor
stream
nitrogen
till
dryness
dri
extract
resuspend
centrifug
min
supernat
transfer
mm
nmr
tube
spectra
record
varian
vnmr
nmr
spectromet
oper
proton
nmr
frequenc
mhz
use
mm
invers
detect
cryoprob
nmr
spectra
record
follow
paramet
digit
resolut
hzpoint
k
complex
data
point
puls
width
pw
relax
delay
acquisit
time
number
transient
roesi
spectra
record
use
standard
chempack
puls
sequenc
groesi
implement
varian
vnmrj
spectromet
softwar
roesi
experi
conduct
mix
time
set
ms
roesi
spectra
collect
bandwidth
ppm
use
complex
data
point
respect
use
relax
delay
result
total
acquisit
time
min
human
prostat
cancer
cell
line
obtain
deutsch
sammlung
von
mikroorganismen
und
zellkulturen
braunschweig
dsmz
acc
colon
cancer
cell
line
obtain
medic
immunolog
depart
martin
hallewittenberg
prof
selig
cell
grown
monolay
adher
cell
line
routin
cultur
rpmi
roswel
park
memori
institut
supplement
heatinactiv
fetal
bovin
serum
fb
lglutamin
polystyren
flask
corn
life
scienc
uk
maintain
humidifi
atmospher
cell
plate
densiti
plate
allow
attach
plate
h
h
media
replac
rpmi
media
contain
resin
extract
three
concentr
use
extract
dri
extract
prepar
section
initi
dissolv
dmso
concentr
mgml
dilut
rpmi
medium
dmso
concentr
assay
exceed
cytotox
tumor
cell
h
medium
taken
xttsolut
phenylamino
carbonyl
hydroxid
roch
appli
scienc
mannheim
germani
ad
well
plate
incub
anoth
h
final
concentr
mgml
absorb
measur
nm
refer
wavelength
nm
use
micropl
reader
beckman
coulter
dtx
multimod
reader
mean
triplic
experi
dose
use
calcul
repeat
passag
cancer
cell
line
digitonin
use
posit
drug
control
reagent
solut
prepar
accord
protocol
establish
cayman
chemic
ann
arbor
mi
usa
inhibit
assay
meoh
extract
prepar
dissolv
neat
dmso
dilut
reaction
buffer
final
dmso
concentr
vv
extract
test
dose
replic
concentr
reaction
conduct
enzym
presenc
heme
cofactor
enzym
incub
min
serial
dilut
liquoric
extract
reaction
buffer
determin
enzym
activ
posit
control
heat
inactiv
enzym
use
neg
control
enzym
activ
arachidon
acid
ad
well
fluoresc
product
reaction
measur
nm
use
micropl
reader
percent
inhibit
cox
enzym
determin
compar
extract
load
well
posit
neg
control
commerci
avail
inhibitor
cayman
chemic
ann
arbor
mi
usa
valu
use
posit
refer
comparison
spectrophotometr
method
use
reagent
adapt
tp
assay
glycyrrhiza
root
extract
prepar
cold
extract
shake
h
use
meoh
plant
debri
remov
centrifug
solvent
remov
evapor
nitrogen
follow
lyophil
residu
dissolv
methanol
obtain
solut
concentr
mgml
folin
ciocalteau
reagent
ad
test
tube
contain
extract
content
mix
satur
sodium
carbon
solut
ad
tube
volum
adjust
ml
addit
ml
milliq
water
content
mix
vigor
tube
allow
stand
room
temperatur
min
centrifug
min
absorb
supernat
read
nm
blank
sampl
extract
fraction
use
background
subtract
caffeic
acid
use
standard
calibr
curv
concentr
mgml
assay
carri
triplic
address
issu
potenti
variat
antiinflammatori
activ
differ
speci
access
measur
abil
methanol
extract
sampl
inhibit
enzym
involv
inflamm
process
fig
g
glabra
show
inhibitori
effect
cox
lox
product
studi
extract
prepar
g
glabra
g
uralensi
among
effect
one
wherea
extract
g
echinata
least
effect
one
test
dose
previou
investig
conclud
g
antiinflammatori
compound
licoric
act
inhibit
releas
inflammatori
mediat
nevertheless
found
inact
assay
setup
dose
contrast
result
liquiritin
major
flavonoid
glycyrrhiza
sp
activ
assay
valu
addit
triterpen
saponin
numer
pharmacolog
activ
polyphenol
quantiti
isol
glycyrrhiza
sp
might
account
potent
antiinflammatori
effect
find
suggest
regard
inhibit
enzym
assay
phenylpropanoid
constitut
indispens
part
licoric
antiinflammatori
efficaci
argu
possibl
synergist
least
addit
effect
sever
secondari
metabolit
target
differ
enzym
involv
inflamm
posit
relationship
appear
exist
total
polyphenol
tp
content
antiinflammatori
activ
speci
potenti
correl
phenol
antioxid
activ
access
demonstr
potent
antiinflammatori
effect
enrich
tp
ie
g
glabra
g
uralensi
show
best
effect
similar
trend
opposit
side
observ
speci
low
tp
ie
g
echinata
fig
thu
total
activ
crude
methanol
extract
appear
dominantli
correl
tp
content
differ
across
speci
note
signific
differ
tp
antiinflammatori
effect
observ
sampl
belong
speci
come
differ
geograph
origin
data
support
observ
licoric
effect
cox
inhibitor
provid
insight
natur
compound
mediat
effect
increas
evid
literatur
point
toward
mark
cytotox
effect
found
licoric
flavonoid
includ
isoliquiritigenin
object
also
investig
cytotox
potenti
licoric
extract
differ
flavonoid
composit
reveal
chemic
analysi
sampl
test
growth
inhibit
mutat
androgen
depend
prostat
androgen
independ
colon
cancer
cell
line
dose
extract
show
weak
inhibit
assay
setup
except
g
inflata
valu
respect
high
content
moder
cytotox
compound
polyphenol
chalcon
g
inflata
probabl
respons
growth
inhibit
effect
relev
amount
licochalcon
major
isoprenyl
retrochalcon
g
inflata
absent
speci
sampl
reveal
nmr
analysi
thu
pure
licochalcon
test
separ
exhibit
signific
activ
lower
valu
suggest
like
main
mediat
cytotox
g
inflata
extract
inde
sever
laboratori
evidenc
mark
cytotox
effect
licochalcon
variou
cancer
cell
line
includ
lung
colon
prostat
skin
cancer
cell
line
sever
retrochalcon
licochalcon
c
present
g
inflata
extract
may
act
addit
even
synergist
licochalcon
result
provid
insight
metabolit
mediat
licoric
biolog
effect
concur
previou
scientif
evid
polyphenol
contribut
larg
extent
licoric
medicin
use
case
deglycyrrhizin
licoric
dgl
author
declar
conflict
interest
author
declar
studi
includ
work
patient
anim
need
approv
appropri
ethic
committe
irb
